SGPL1 and hepatocellular carcinoma: Once again, this study raised the possibility that the ceramide‐S1P rheostat may, not be fully operational in all cancers, especially in cancers in which not only SPL, but also other enzymes responsible for producing LPI and/or LPG from sphingolipids via PE were enhanced, based mainly on our HCC‐related study.20